A new pullulan based doxorubicin macromolecular prodrug was synthesized and tested in vitro. Folic acid conjugation conferred to the supramolecular system active targeting properties. Doxorubicin was conjugated to pullulan via pH sensitive bonds yielding a derivative stable in plasma. At pH 5.5 the drug was completely released in 96 hours. The carrier was found to be selectively toxic to folate overexpressing cell lines.
Pullulan Bioconjugates For Tumor Targeting.
SCOMPARIN, ANNA;SALMASO, STEFANO;MASTROTTO, FRANCESCA;BERSANI, SARA;CALICETI, PAOLO
2009
Abstract
A new pullulan based doxorubicin macromolecular prodrug was synthesized and tested in vitro. Folic acid conjugation conferred to the supramolecular system active targeting properties. Doxorubicin was conjugated to pullulan via pH sensitive bonds yielding a derivative stable in plasma. At pH 5.5 the drug was completely released in 96 hours. The carrier was found to be selectively toxic to folate overexpressing cell lines.File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
